Trial intelligence / Profile preview

Investigating the effect of PRP and G-CSF on infertility

IRCT20220813055671N1Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jan 2023
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of granulocyte colony-stimulating factor and platelet-rich plasma in Recurrent Implantation Failure (RIF) and female infertility, sponsored by Isfahan University of Medical Sciences. Started Jan 2023; status: completed.

02

Drugs

granulocyte colony-stimulating factorplatelet-rich plasma
03

Conditions

Recurrent Implantation Failure (RIF)female infertility

Beyond the preview

Go deeper on IRCT20220813055671N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220813055671N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call